Johnson & Johnson Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31)
Johnson & Johnson (JNJ) reported Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) of $866.00 million for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpense · last filed 2012-11-09
- Johnson & Johnson finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for the quarter ending 2012-09-30 was $378.00M, a 80.86% increase year-over-year.
- Johnson & Johnson finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for the quarter ending 2012-07-01 was $283.00M, a 33.49% increase year-over-year.
- Johnson & Johnson finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for the quarter ending 2012-04-01 was $205.00M, a 7.89% increase year-over-year.
- Johnson & Johnson finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for the quarter ending 2012-01-01 was $241.00M, a 9.55% increase year-over-year.
- Johnson & Johnson finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for fiscal 2012 was $852.00M, a 13.90% increase from fiscal 2011.
- Johnson & Johnson finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for fiscal 2011 was $748.00M, a 10.81% increase from fiscal 2010.
- Johnson & Johnson finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for fiscal 2010 was $675.00M, a 14.34% decline from fiscal 2008.
- Johnson & Johnson finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for fiscal 2008 was $788.00M.
| Period end | Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) 3 month | Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) 6 month | Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) 9 month | Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-09-30 | $378.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $661.00M derived: sum of 2 quarters · filed 2012-11-09 | $866.00M 10-Q · filed 2012-11-09 | $1.11B derived: sum of 4 quarters · filed 2012-11-09 |
| 2012-07-01 | $283.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $488.00M 10-Q · filed 2012-08-02 | $729.00M derived: sum of 3 quarters · filed 2012-08-02 | $938.00M derived: sum of 4 quarters · filed 2012-11-09 |
| 2012-04-01 | $205.00M 10-Q · filed 2012-05-07 | $446.00M derived: sum of 2 quarters · filed 2012-05-07 | $655.00M derived: sum of 3 quarters · filed 2012-11-09 | $867.00M derived: sum of 4 quarters · filed 2012-11-09 |
| 2012-01-01 | $241.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $450.00M derived: sum of 2 quarters · filed 2012-11-09 | $662.00M derived: sum of 3 quarters · filed 2012-11-09 | $852.00M 10-K · filed 2012-02-23 |
| 2011-10-02 | $209.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $421.00M derived: sum of 2 quarters · filed 2012-11-09 | $611.00M 10-Q · filed 2012-11-09 | $831.00M derived: sum of 4 quarters · filed 2012-11-09 |
| 2011-07-03 | $212.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | $402.00M 10-Q · filed 2011-08-09 | $622.00M derived: sum of 3 quarters · filed 2012-02-23 | $797.00M derived: sum of 4 quarters · filed 2012-02-23 |
| 2011-04-03 | $190.00M 10-Q · filed 2011-05-10 | $410.00M derived: sum of 2 quarters · filed 2012-02-23 | $585.00M derived: sum of 3 quarters · filed 2012-02-23 | |
| 2011-01-02 | $220.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $395.00M derived: sum of 2 quarters · filed 2012-02-23 | $748.00M 10-K · filed 2012-02-23 | |
| 2010-10-03 | $175.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-10 | $528.00M 10-Q · filed 2010-11-10 | ||
| 2010-07-04 | $353.00M 10-Q · filed 2010-08-11 | |||
| 2010-01-03 | $675.00M 10-K · filed 2012-02-23 | |||
| 2008-12-28 | $788.00M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |